CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling
Jianpeng Yu(Duke University), Zhiqun Shang(Second Hospital of Tianjin Medical University), Tianyu Shen(Second Hospital of Tianjin Medical University), Shimiao Zhu(Second Hospital of Tianjin Medical University), Wun‐Jae Kim(Chungbuk National University), Tangxi Hao(Second Hospital of Tianjin Medical University), Xuan‐Mei Piao(Chungbuk National University), Yang Li(Capital Medical University), Zheng Zhang(Second Hospital of Tianjin Medical University), Hanlin Li(Second Hospital of Tianjin Medical University), Yuanjie Niu(Second Hospital of Tianjin Medical University), Long Yang, Yang Zhao(South China Agricultural University), Changyi Quan
Cited by 7
Related Papers
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
|Nucleic Acids Research|2019|212
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
|Journal of Experimental & Clinical Cancer Research|2020|106
Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
|British Journal of Cancer|2017|73